While GLP-1 agonists have demonstrated significant benefits for glycemic control and weight management, patients and clinicians must consider potential interactions with thyroid function and the specific considerations relevant to autoimmune thyroid disease
This ensures the medications effectiveness while reducing the risk of discomfort
Wharton S, Freitas P, Hjelmesaeth J, et al
All product information provided on this website is for informational and educational purposes only
If standard doses are not tolerated, clinically appropriate alternatives might include slower titration (still within SmPC guidelines), switching to a different GLP-1 receptor agonist, considering other medication classes, enhancing diet/lifestyle support, or specialist review
The SNP-based heritability estimated on the observed scale was 0.78% (SE = 0.04%), which was highly significant (Z = 21.09, P-value = 9.41 10), further supporting a polygenic basis for ovarian cancer